Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts

Journal of Molecular and Cellular Cardiology
C D WollebenP K Siegl

Abstract

We have confirmed the findings of Kantor and colleagues that ischemia-induced fibrillation in isolated Langendorff-perfused rat hearts can be prevented by glyburide, a blocker of ATP-dependent K channels. These data suggest that block of ATP-dependent K current [IK(ATP)] is a novel antiarrhythmic mechanism. This hypothesis was further tested by evaluating the effects of another sulfonylurea IK(ATP) blocker, tolbutamide (1 mM) and two agents known to activate these channels in cardiac tissue, BRL 34915 (10 microM) and pinacidil (30 microM). Similar to glyburide, tolbutamide was also effective in preventing fibrillation in this isolated rat heart model. The IK(ATP) activators enhanced the rate of tachycardia and shortened the time required for the hearts to develop fibrillation. Coadministration of glyburide with either IK(ATP) activator prevented their effects. It is concluded that activation of IK(ATP) during global ischemia contributes to the development of fibrillation in the perfused rat heart model.

Citations

Apr 11, 2000·Journal of Molecular and Cellular Cardiology·G J Grover, K D Garlid
Jun 1, 1992·Cardiovascular Drugs and Therapy·W A Coetzee
Aug 1, 1990·Naunyn-Schmiedeberg's Archives of Pharmacology·J K SmallwoodM I Steinberg
Aug 1, 1993·Cardiovascular Drugs and Therapy·A A Wilde
Mar 1, 1995·Cardiovascular Drugs and Therapy·W HaverkampG Breithardt
Aug 3, 2005·Annals of Biomedical Engineering·Beatriz TrénorFulgencio Montilla
Nov 20, 1990·European Journal of Pharmacology·G J GroverP G Sleph
Jul 1, 1996·Diabetes Research and Clinical Practice·A Lomuscio, C Fiorentini
Jul 1, 1996·Diabetes Research and Clinical Practice·A Végh, J G Papp
Apr 28, 2004·Cell Calcium·Ursula RavensOttó Hála
Jun 28, 2005·Journal of Molecular and Cellular Cardiology·Thomas P Flagg, Colin G Nichols
Aug 4, 1997·The American Journal of Cardiology·F C BrosiusD Sun
Aug 26, 2000·European Journal of Pharmacology·W A CoetzeeM Avkiran
May 12, 2001·European Journal of Pharmacology·A J WorkmanB J Northover
Dec 5, 1996·European Journal of Pharmacology·Y X WangX B Zhou
Feb 13, 1999·European Journal of Pharmacology·N E El-ReyaniJ G Papp
Dec 5, 2003·Journal of Molecular and Cellular Cardiology·Bartosz BalanaUrsula Ravens
Aug 23, 2002·Pharmacology & Therapeutics·Alan Wickenden
Dec 5, 1997·Journal of Cardiovascular Pharmacology·X H Xiao, L K Holley
Dec 1, 1992·British Journal of Pharmacology·H SakutaY Watanabe
Nov 1, 1994·British Journal of Pharmacology·D FultonJ Quilley
Aug 31, 1999·Journal of Cardiovascular Electrophysiology·T J WuP S Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.